{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 928"}, "official-title": {"#tail": "\n\t", "#text": "To amend title XVIII of the Social Security Act to\n\t\t  deliver a meaningful benefit and lower prescription drug prices under the\n\t\t  Medicare Program."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130228", "#text": "February 28, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in\n\t\t\t addition to the Committee on ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the\n\t\t\t Speaker, in each case for consideration of such provisions as fall within the\n\t\t\t jurisdiction of the committee concerned", "@committee-id": "HWM00", "#text": "Ways and\n\t\t\t Means"}], "sponsor": {"#tail": " (for\n\t\t\t herself, ", "#text": "Ms. Schakowsky", "@name-id": "S001145"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Farr", "@name-id": "F000030"}, {"#tail": ",\n\t\t\t ", "#text": "Ms. Lee of California", "@name-id": "L000551"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. George Miller of California", "@name-id": "M000725"}, {"#tail": ") introduced the\n\t\t\t following bill; which was referred to the ", "#text": "Ms. Pingree of Maine", "@name-id": "P000597"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H8FC21660CCED4E72AFBBA42F90B13C7F", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Medicare Prescription Drug Savings and\n\t\t\t Choice Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "@display-inline": "no-display-inline", "#text": "\n      ", "@id": "H9A50376F04A745B1BBD451758ADFD99D"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Establishment of\n\t\t\t Medicare operated prescription drug plan option"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by inserting after ", "@entity-type": "act", "#text": "Subpart 2 of part D of title XVIII of the Social Security\n\t\t\t Act", "@value": "Social Security Act/t:XVIII/pt:D/spt:2"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " the\n\t\t\t following new section:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 1860D\u201311", "@value": "Social Security Act/s:1860D\u201311"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013111", "@value": "usc/42/1395w\u2013111"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "quoted-block": {"@act-name": "Social Security Act", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "@style": "traditional", "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "1860D\u201311A."}, "header": {"#tail": "\n            ", "#text": "Medicare operated prescription drug plan\n\t\t  option"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "section 1860D\u201311", "@value": "Social Security Act/s:1860D\u201311"}, {"#tail": " shall offer one or\n\t\t\t\tmore Medicare operated prescription drug plans (as defined in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ")\n\t\t\t\twith a service area that consists of the entire United States and shall enter\n\t\t\t\tinto negotiations in accordance with subsection (b) with pharmaceutical\n\t\t\t\tmanufacturers to reduce the purchase cost of covered part D drugs for eligible\n\t\t\t\tpart D individuals who enroll in such a plan.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Social Security Act/s:1860D-11A/ss:c", "@proposed": "true"}], "#text": "Notwithstanding any\n\t\t\t\tother provision of this part, for each year (beginning with 2012), in addition\n\t\t\t\tto any plans offered under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "@display-inline": "yes-display-inline", "#text": "\n              ", "@id": "HEE9B43FCFC6C430F819649AF2D3C05B7", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", for\n\t\t\t\tpurposes of offering a Medicare operated prescription drug plan under this\n\t\t\t\tsection, the ", "@entity-type": "act", "#text": "section 1860D\u201311(i)", "@value": "Social Security Act/s:1860D\u201311/ss:i"}, {"#tail": " shall negotiate with pharmaceutical manufacturers with\n\t\t\t\trespect to the purchase price of covered part D drugs in a Medicare operated\n\t\t\t\tprescription drug plan and shall encourage the use of more affordable\n\t\t\t\ttherapeutic equivalents to the extent such practices do not override medical\n\t\t\t\tnecessity as determined by the prescribing physician. To the extent practicable\n\t\t\t\tand consistent with the previous sentence, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall implement\n\t\t\t\tstrategies similar to those used by other Federal purchasers of prescription\n\t\t\t\tdrugs, and other strategies, including the use of a formulary and formulary\n\t\t\t\tincentives in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", to reduce the purchase cost of covered part D\n\t\t\t\tdrugs.", "@entity-type": "act", "#text": "subsection (e)", "@value": "Social Security Act/s:1860D-11A/ss:e", "@proposed": "true"}], "#text": "Notwithstanding ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Negotiations"}, "#text": "\n              ", "@id": "HE1B68656E90C46E1AD5BC814D8B35077"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". Such a plan\n\t\t\t\tmay offer supplemental prescription drug coverage in the same manner as other\n\t\t\t\tqualified prescription drug coverage offered by other prescription drug\n\t\t\t\tplans.", "@entity-type": "act", "#text": "section 1860D\u20132(a)(1)(A)", "@value": "Social Security Act/s:1860D\u20132/ss:a/p:1/sp:A"}, "term": {"#tail": " means a\n\t\t\t\tprescription drug plan that offers qualified prescription drug coverage and\n\t\t\t\taccess to negotiated prices described in ", "#text": "Medicare operated prescription drug plan"}, "#text": "For purposes of this\n\t\t\t\tpart, the term "}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Medicare\n\t\t\t\toperated prescription drug plan defined"}, "#text": "\n              ", "@id": "H4B84CA5A79B841558B0ED48DA7845D0D"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Monthly\n\t\t\t\tbeneficiary premium"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to be charged under a Medicare operated\n\t\t\t\tprescription drug plan shall be uniform nationally. Such premium for months in\n\t\t\t\t2014 and each succeeding year shall be based on the average monthly per capita\n\t\t\t\tactuarial cost of offering the Medicare operated prescription drug plan for the\n\t\t\t\tyear involved, including administrative expenses.", "@entity-type": "act", "#text": "section 1860D\u20132(a)(1)(A)", "@value": "Social Security Act/s:1860D\u20132/ss:a/p:1/sp:A"}, "#text": "The monthly beneficiary premium for\n\t\t\t\tqualified prescription drug coverage and access to negotiated prices described\n\t\t\t\tin "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Qualified\n\t\t\t\tprescription drug coverage"}, "#text": "\n                ", "@id": "H4F4EF94FE8F0453590957D356D7DEF7E"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may adjust the amount of the premium charged under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(1)", "@value": "Social Security Act/s:1860D-11A/ss:d/p:1", "@proposed": "true"}], "#text": "Insofar as a Medicare operated\n\t\t\t\tprescription drug plan offers supplemental prescription drug coverage, the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Supplemental\n\t\t\t\tprescription drug coverage"}, "#text": "\n                ", "@id": "HC2A96641380F49E2A817D0150C4090E2"}], "#text": "\n              ", "@id": "HB44A31F7D5D9435283230EF90EABC785"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Use of a\n\t\t\t\tformulary and formulary incentives"}, "paragraph": [{"#tail": "\n              ", "@id": "HB064DB7ACC294FBEB3BC425AF4EE071A", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\testablish and apply a formulary (and may include formulary incentives described\n\t\t\t\tin ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ") in accordance with this subsection in order to\u2014", "@entity-type": "act", "#text": "paragraph (2)(C)(ii)", "@value": "Social Security Act/s:1860D-11A/ss:e/p:2/sp:C/cl:ii", "@proposed": "true"}], "#text": "With respect to the\n\t\t\t\toperation of a Medicare operated prescription drug plan, the ", "@display-inline": "yes-display-inline"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "increase patient\n\t\t\t\tsafety;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H4A77867917B546CF9C54AE8D32336136", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "increase appropriate use and reduce\n\t\t\t\tinappropriate use of drugs; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H86C9611005E24F5DA3BA297963831F05", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "reward\n\t\t\t\tvalue."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "HE148987A34C94CE5A1BD76AF1F312CFC", "#text": "\n                  "}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall consider\n\t\t\t\tclinical benefit and price.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In selecting covered\n\t\t\t\tpart D drugs for inclusion in a formulary, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "H19F7376C78CF40BA9D463F87FB901E10"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}, "#text": "consider safety\n\t\t\t\tconcerns including those identified by the Federal "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H6976F29F2D3E4B5CAD9FBA7F75B1DA10", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "use available data and evaluations, with\n\t\t\t\tpriority given to randomized controlled trials, to examine clinical\n\t\t\t\teffectiveness, comparative effectiveness, safety, and enhanced compliance with\n\t\t\t\ta drug regimen;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H86FB72A4B60C47D692B1C4D458A475B9", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "use the same\n\t\t\t\tclasses of drugs developed by United States Pharmacopeia for this part;"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "H538C6215DE244CFFBE3587C132195F00", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "consider\n\t\t\t\tevaluations made by\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "7528"}, {"#tail": ";", "@entity-type": "act", "#text": "section 1013 of Medicare Prescription Drug, Improvement, and Modernization Act\n\t\t\t\tof 2003", "@value": "Medicare Prescription Drug, Improvement, and Modernization Act of 2003/s:1013"}], "#text": "the "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "HEBFB0D1C0BAE4702A9B2261EC3F802E1", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "federal-body", "#text": "Secretary of Veterans Affairs", "@entity-id": "3600"}, "#text": "other Federal\n\t\t\t\tentities, such as the "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "HB2DC7B7470524BCC98A7517C8010EEC5", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "other private\n\t\t\t\tand public entities, such as the Drug Effectiveness Review Project and Medicaid\n\t\t\t\tprograms; and"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H9FF1053C604942D780703F9CE67AF54D", "#text": "\n                      "}], "#text": "\n                    ", "@id": "H6460E9A88B094708B9395C80A330D09F"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "recommend to the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "those drugs in a class that provide a\n\t\t\t\tgreater clinical benefit, including fewer safety concerns or less risk of\n\t\t\t\tside-effects, than another drug in the same class that should be included in\n\t\t\t\tthe formulary;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H3C21577C06EC44B4B736C36BB0ECB55A", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "those drugs in a class that provide less\n\t\t\t\tclinical benefit, including greater safety concerns or a greater risk of\n\t\t\t\tside-effects, than another drug in the same class that should be excluded from\n\t\t\t\tthe formulary; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "HB3781D2D8908431198D3FD0F3A673759", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to competitively bid (or negotiate) for placement on the\n\t\t\t\tformulary.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "drugs in a class\n\t\t\t\twith same or similar clinical benefit for which it would be appropriate for the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H28FAAB2748984CB4A0E0C15C352EA815", "#text": "\n                      "}], "#text": "\n                    ", "@id": "H82BFE11C14384EE3980D9F577072BA75"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Role of\n\t\t\t\tAHRQ"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be responsible for assessing\n\t\t\t\tthe clinical benefit of covered part D drugs and making recommendations to the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Director of the\n\t\t\t\tAgency for Healthcare Research and Quality", "@entity-id": "7528"}, {"#tail": " regarding which drugs should be included in the formulary. In\n\t\t\t\tconducting such assessments and making such recommendations, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tshall\u2014", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "7528"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "@id": "H4221D0EC6B6647E6A6B1836618C9EE93"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "have a lower cost and provide a greater\n\t\t\t\tclinical benefit than other drugs;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H07F3D278B56C43339C7E42D0264B442B", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "have a lower cost than other drugs with\n\t\t\t\tsame or similar clinical benefit; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H2E53528F0E7442BE8141CCD0C054002A", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "drugs that have the same cost but provide\n\t\t\t\tgreater clinical benefit than other drugs.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H0C5298EB2C054765A176E9DFAA2B7F5E", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", after\n\t\t\t\ttaking into consideration the recommendations under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall\n\t\t\t\testablish a formulary, and formulary incentives, to encourage use of covered\n\t\t\t\tpart D drugs that\u2014", "@entity-type": "act", "#text": "subparagraph (B)(v)", "@value": "Social Security Act/s:1860D-11A/ss:e/p:2/sp:B/cl:v", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H36129663BA6C49F897BE408FDE8D5459"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Tiered copayments.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "HE812D696028244C7AE1201E77B2F9159", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Reference\n\t\t\t\tpricing."}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "HAF339E88185F4B68885ED79E31643EAB", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Prior\n\t\t\t\tauthorization."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H2750E3A099A8407EB5143ACDAB01971E", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Step\n\t\t\t\ttherapy."}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "HBF928DA0407F44A0927F9D8ADE9E8695", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Medication therapy\n\t\t\t\tmanagement."}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "@id": "HE04B3FFE5FE94AD98DC1B7737D3BD463", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Generic drug substitution.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(VI)"}, "@id": "H6A773E08E528424C99258C0F9A8389D5", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Formulary\n\t\t\t\tincentives"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may be in the form of one or more of the\n\t\t\t\tfollowing:", "@entity-type": "act", "#text": "clause (i)", "@value": "Social Security Act/s:1860D-11A/ss:e/p:2/sp:C/cl:i", "@proposed": "true"}, "#text": "The formulary\n\t\t\t\tincentives under ", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H145965C15C3E48048E91CBBE68CA1E03"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the elimination of\n\t\t\t\tcost sharing would be expected to increase compliance with a drug regimen;\n\t\t\t\tand"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "HD565BB4B1FCD4DDA8B4D4868D6C11217", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "compliance would\n\t\t\t\tbe expected to produce savings under part A or B or both."}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H04B56F6AC7524BBDAAE188A463951C59", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Flexibility"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may decide not to impose any cost-sharing for a covered part D drug\n\t\t\t\tfor which\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In applying such formulary incentives the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H0724D3C331A94A269623D37AD2E121ED"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Consideration of\n\t\t\t\tAHRQ recommendations"}, "#text": "\n                  ", "@id": "HFD62FDC643F942D781C1A19955C0F9C6"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Development of\n\t\t\t\tinitial formulary"}, "#text": "\n                ", "@id": "H11D76EF2DCAA440E9BAE3E35E27E864E"}, {"#tail": "\n              ", "@id": "H0D309B78FE1C4C38996216341905ADAB", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Limitations on\n\t\t\t\tformulary"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In any formulary established under this subsection, the\n\t\t\t\tformulary may not be changed during a year, except\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to add a generic\n\t\t\t\tversion of a covered part D drug that entered the market;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HEA14EBDD2EAF49E097C5E61B21B22BD7", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "to remove such a\n\t\t\t\tdrug for which a safety problem is found; and"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HFEF98D5E39BB4AD08C38DBBE4B189F56", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " identifies\n\t\t\t\tas a drug which treats a condition for which there has not previously been a\n\t\t\t\ttreatment option or for which a clear and significant benefit has been\n\t\t\t\tdemonstrated over other covered part D drugs.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "to add a drug that the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H8BE98E81217543CF88594304C70AA470", "#text": "\n                  "}]}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "to review petitions from drug\n\t\t\t\tmanufacturers, health care provider organizations, patient groups, and other\n\t\t\t\tentities for inclusion of a drug in, or other changes to, such formulary;\n\t\t\t\tand", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H62F35AC608D84614A39220BCEE2A438F", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "to recommend any\n\t\t\t\tchanges to the formulary established under this subsection."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HC0A662B7A7D046A3A73846D6E5E2F2CF", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Use of advisory\n\t\t\t\tcommittee"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\testablish and appoint an advisory committee (in this paragraph referred to as\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": {"#tail": ")\u2014", "#text": "advisory committee"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "@id": "H675F69A2E7D9498B8CAB522BF770B336"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall select members based on their knowledge of pharmaceuticals and\n\t\t\t\tthe Medicare population. Members shall be deemed to be special Government\n\t\t\t\temployees for purposes of applying the conflict of interest provisions under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", and no waiver of such provisions\n\t\t\t\tfor such a member shall be permitted.", "@entity-type": "uscode", "#text": "section 208 of title 18, United States Code", "@value": "usc/18/208"}], "#text": "The advisory committee shall be composed of\n\t\t\t\t9 members and shall include representatives of physicians, pharmacists, and\n\t\t\t\tconsumers and others with expertise in evaluating prescription drugs. The\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Composition"}, "#text": "\n                  ", "@id": "HA41F40B87BB94A1DA538F9D561596844"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tadvisory committee shall consult, as necessary, with physicians who are\n\t\t\t\tspecialists in treating the disease for which a drug is being\n\t\t\t\tconsidered."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Consultation"}, "#text": "\n                  ", "@id": "H44B04210B013448AA34C3165B9950949"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "clinical\n\t\t\t\teffectiveness;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HEB048B52FABE41C2854DEAFCE5683774", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "comparative\n\t\t\t\teffectiveness;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HA766A5D1D66A41CA9B0E4B433E62251D", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "safety;\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "HA77381C41DB2418A87625B89121C3624", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "enhanced\n\t\t\t\tcompliance with a drug regimen."}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "HC25BF25184FA4DB2AF7962863B383A4E", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Request for\n\t\t\t\tstudies"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or an\n\t\t\t\tacademic or research institution to study and make a report on a petition\n\t\t\t\tdescribed in ", "@entity-type": "federal-body", "#text": "Agency for Healthcare Research and Quality", "@entity-id": "7528"}, {"#tail": " in order to assess\u2014", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Social Security Act/s:1860D-11A/ss:e/p:4/sp:A/cl:ii", "@proposed": "true"}], "#text": "The advisory\n\t\t\t\tcommittee may request the ", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "@id": "HFC09F2AB32B642DAAEA156C3FA1A360D"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "whether a covered part D drug is found to\n\t\t\t\tprovide a greater clinical benefit, including fewer safety concerns or less\n\t\t\t\trisk of side-effects, than another drug in the same class that is currently\n\t\t\t\tincluded in the formulary and should be included in the formulary;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HC0729CDE8F1949C38C43702D1B73B61B", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "whether a covered part D drug is found to\n\t\t\t\tprovide less clinical benefit, including greater safety concerns or a greater\n\t\t\t\trisk of side-effects, than another drug in the same class that is currently\n\t\t\t\tincluded in the formulary and should not be included in the formulary;\n\t\t\t\tand", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H7B77258313304BB09A964FE0BBFAD5B1", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "whether a\n\t\t\t\tcovered part D drug has the same or similar clinical benefit to a drug in the\n\t\t\t\tsame class that is currently included in the formulary and whether the drug\n\t\t\t\tshould be included in the formulary."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "H31DD557599AB42598CF4E08493EB1136", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Recommendations"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tregarding\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The\n\t\t\t\tadvisory committee shall make recommendations to the "}, "#text": "\n                  ", "@id": "HF3081983A8174BF5AF56CA4334F7B549"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Raw data from clinical trials on the safety\n\t\t\t\tand effectiveness of the drug.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HD3EB95A0F6DB45C1B486EAF18F55067D", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Any data from\n\t\t\t\tclinical trials conducted using active controls on the drug or drugs that are\n\t\t\t\tthe current standard of care."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HE84860BAD2A44F6494D411C13AC84C36", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Any available\n\t\t\t\tdata on comparative effectiveness of the drug."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "H6DEAC541BB504B10BA34672433E53330", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " requires for the advisory committee to complete its\n\t\t\t\treview.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Any other\n\t\t\t\tinformation the "}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "H77201BE84A214FE6B46D4799E954C499", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(F)"}, "header": {"#tail": "\n                  ", "#text": "Limitations on\n\t\t\t\treview of manufacturer petitions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to a\n\t\t\t\tcovered part D drug unless the petition is accompanied by the following:", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Social Security Act/s:1860D-11A/ss:e/p:4/sp:A/cl:ii", "@proposed": "true"}, "#text": "The advisory committee shall not review a\n\t\t\t\tpetition of a drug manufacturer under ", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "@id": "H4BB676D3640849A8925C0B01B80DC219"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall review the recommendations of the advisory committee and if the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\taccepts such recommendations the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall modify the formulary\n\t\t\t\testablished under this subsection accordingly. Nothing in this section shall\n\t\t\t\tpreclude the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " from adding to the formulary a drug for which the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or the advisory\n\t\t\t\tcommittee has not made a recommendation.", "@entity-type": "federal-body", "#text": "Director of the Agency for Healthcare Research and Quality", "@entity-id": "7528"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(G)"}, "header": {"#tail": "\n                  ", "#text": "Response to\n\t\t\t\trecommendations"}, "#text": "\n                  ", "@id": "H3C5240F618B64C5CA0CACFFA5952103C"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\tprovide timely notice to beneficiaries and health professionals about changes\n\t\t\t\tto the formulary or formulary incentives.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(H)"}, "header": {"#tail": "\n                  ", "#text": "Notice of\n\t\t\t\tchanges"}, "#text": "\n                  ", "@id": "HD09640C9BB5B4B6497A83CDB8D2EBC1D"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Adding drugs to\n\t\t\t\tthe initial formulary"}, "#text": "\n                ", "@id": "HED4C6BC4590B42369815ACFDCC4BD6E2"}], "#text": "\n              ", "@id": "HBA8EDE4C9E5D4001A4226DA1C987766F"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall take steps to inform beneficiaries about the availability of a Medicare\n\t\t\t\toperated drug plan or plans including providing information in the annual\n\t\t\t\thandbook distributed to all beneficiaries and adding information to the\n\t\t\t\tofficial public Medicare Web site related to prescription drug coverage\n\t\t\t\tavailable through this part.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n              ", "#text": "Informing\n\t\t\t\tbeneficiaries"}, "#text": "\n              ", "@id": "HCF7C7EF41F3440ABAB2FCDC5C5AF1A42"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " relating to assuring\n\t\t\t\tpharmacy\n\t\t\t\taccess).", "@entity-type": "act", "#text": "section 1860D\u20134(b)(1)", "@value": "Social Security Act/s:1860D\u20134/ss:b/p:1"}, "#text": "Except as\n\t\t\t\tspecifically provided in this section, any Medicare operated drug plan shall\n\t\t\t\tmeet the same requirements as apply to any other prescription drug plan,\n\t\t\t\tincluding the requirements of "}, "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n              ", "#text": "Application of\n\t\t\t\tall other requirements for prescription drug plans"}, "#text": "\n              ", "@id": "H8B8F5E67084D47F19743979DFCF89AFA"}], "#text": "\n            ", "@id": "H772A210AF7BC4876B1659D837BD7A343"}, "#text": "\n\t\t\t\t\t", "@id": "HC4D0B43320CD4CEC829341B9DCD8042D"}, "#text": "\n        ", "@id": "H56A3503C6D044578BF857B302A4285F1"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Conforming\n\t\t\t amendments"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following new\n\t\t\t paragraph:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"act-name": {"#tail": "\n              ", "@parsable-cite": "SSA", "#text": "Social Security Act"}, "#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u20133(a)\n\t\t\t of the ", "@value": "Social Security Act/s:1860D\u20133/ss:a"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 1395w\u2013103(a)", "@value": "usc/42/1395w\u2013103/a"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "quoted-block": {"@act-name": "Social Security Act", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "paragraph": {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ") shall be offered\n\t\t\t\tnationally in accordance with ", "@entity-type": "act", "#text": "section 1860D\u201311A(c)", "@value": "Social Security Act/s:1860D\u201311A/ss:c"}, {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t1860D\u201311A", "@value": "Social Security Act/s:1860D\u201311A"}], "#text": "A Medicare operated\n\t\t\t\tprescription drug plan (as defined in "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Availability of\n\t\t\t\tthe medicare operated prescription drug plan"}, "#text": "\n              ", "@id": "H52FB1342792F43DF8CA88FBA0FC58209"}, "#text": "\n\t\t\t\t\t\t", "@id": "HC4DC782AA4C54F1293A1AEED72434261"}, "#text": "\n          ", "@id": "H307D5E4F23C44E6FAA261C842D010F8E"}, {"#tail": "\n        ", "@id": "H7814F1BFBDBC4B1681EE683C305CA323", "enum": {"#tail": "\n          ", "#text": "(2)"}, "@display-inline": "no-display-inline", "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the\n\t\t\t following new subsection:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u20133 of the\n\t\t\t Social Security Act", "@value": "Social Security Act/s:1860D\u20133"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013103", "@value": "usc/42/1395w\u2013103"}], "@entity-type": "law-citation", "#text": "\n                "}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "subsection": {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The provisions of this section\n\t\t\t\tshall only apply with respect to 2006 through\n\t\t\t\t2013."}, "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n                ", "#text": "Provisions only\n\t\t\t\tapplicable in 2006 through 2013"}, "#text": "\n                ", "@id": "H9DF5C268352B45E78988D61C5E3E11D8"}, "#text": "\n\t\t\t\t\t\t\t", "@id": "H8D74A16A15A04567AB86DA4BF6A9920E"}, "@display-inline": "yes-display-inline", "#text": "\n            ", "@id": "H982EDE6AB8154E219C88BD472FAF302A", "@commented": "no"}, {"@indent": "up1", "#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following new\n\t\t\t paragraph:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u201311(g) of such Act", "@value": "Social Security Act/s:1860D\u201311/ss:g"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42\n\t\t\t U.S.C. 1395w\u2013111(g)", "@value": "usc/42/1395w\u2013111/g"}], "@entity-type": "law-citation", "#text": "\n                "}}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "paragraph": {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A fallback prescription drug plan shall\n\t\t\t\tnot be available after December 31,\n\t\t\t\t2013."}, "enum": {"#tail": "\n                ", "#text": "(8)"}, "header": {"#tail": "\n                ", "#text": "No authority for\n\t\t\t\tfallback plans after 2013"}, "#text": "\n                ", "@id": "H31AC20D299484B16BB6A8ED4DA0D2178"}, "#text": "\n\t\t\t\t\t\t\t", "@id": "H9A7F457888EC46E2B97582CE544CBD56"}, "#text": "\n            ", "@id": "HB6F9287B81174B10901B64188AF61273"}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is\n\t\t\t amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 1860D\u201313(c)(3) of the Social Security Act", "@value": "Social Security Act/s:1860D\u201313/ss:c/p:3"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013113(c)(3)", "@value": "usc/42/1395w\u2013113/c/3"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "H012F332316194CF980B66A1C6E6FB6A9", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " after\n\t\t\t ", "header-in-text": {"#tail": "\n              ", "@style": "OLC", "#text": "and Medicare\n\t\t\t operated prescription drug plans", "@level": "paragraph"}, "#text": "\n                "}, {"#tail": "; and", "header-in-text": {"#tail": "\n              ", "@style": "OLC", "#text": "Fallback\n\t\t\t plans", "@level": "paragraph"}, "#text": "\n                "}], "#text": "in the heading, by\n\t\t\t inserting "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HDAC70F910EE747FEAC253D5D8B0FE541", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " after ", "#text": "or a Medicare operated\n\t\t\t prescription drug plan"}, {"#tail": ".", "#text": "a fallback prescription drug\n\t\t\t plan"}], "#text": "by inserting ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H4A7F8FF858D44B89BA4C7AB09A4A0D7C", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u201316(b)(1) of the Social\n\t\t\t Security Act", "@value": "Social Security Act/s:1860D\u201316/ss:b/p:1"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.1395w\u2013116(b)(1)", "@value": "usc"}], "@entity-type": "law-citation", "#text": "\n              "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "#text": "\n          ", "@id": "HC4E31891264B40AF8A73BB81CEEFDB68", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (C)", "@value": "Social Security Act/s:1860D\u201316/ss:b/p:1/sp:C"}, "#text": "in ", "quote": {"#tail": " after the semicolon at the end;", "#text": "and"}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H55027CA8E63A4BCFBB5471290E458AC3", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking the period at the end and inserting ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (D)", "@value": "Social Security Act/s:1860D\u201316/ss:b/p:1/sp:D"}, "#text": "in ", "quote": {"#tail": ";\n\t\t\t and", "#text": "; and"}}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H4F3965E9CF2C43C681705BA58DF35662", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "by adding at the\n\t\t\t end the following new subparagraph:"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "quoted-block": {"#tail": "\n\t\t\t\t\t", "subparagraph": {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t1860D\u201311A", "@value": "Social Security Act/s:1860D\u201311A"}, "#text": "payments for\n\t\t\t\texpenses incurred with respect to the operation of Medicare operated\n\t\t\t\tprescription drug plans under "}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "HAAB9BB2D7E1B47C2AACC34FA9746B2D7", "#text": "\n                "}, "#text": "\n\t\t\t\t\t\t\t", "@id": "H41A9D75961FB4D70994A874A8A4A513F", "after-quoted-block": {"#tail": "\n            ", "#text": "."}}, "#text": "\n            ", "@id": "H63023BBC588D4E6F81ECC61B339DB3F5"}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following new\n\t\t\t paragraph:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u201341(a) of the Social Security\n\t\t\t Act", "@value": "Social Security Act/s:1860D\u201341/ss:a"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013151(a)", "@value": "usc/42/1395w\u2013151/a"}], "@entity-type": "law-citation", "#text": "\n              "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "quoted-block": {"#tail": "\n\t\t\t\t", "#text": "\n\t\t\t\t\t\t", "paragraph": {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t1860D\u201311A(c)", "@value": "Social Security Act/s:1860D\u201311A/ss:c"}, "term": {"#tail": " has the meaning given such term in ", "#text": "Medicare operated\n\t\t\t\tprescription drug plan"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(19)"}, "header": {"#tail": "\n              ", "#text": "Medicare\n\t\t\t\toperated prescription drug plan"}, "#text": "\n              ", "@id": "HBD9BC53702D34848AAA90450E647C0FE"}, "@id": "HC129E958BEB24B778648748091AF1309", "after-quoted-block": {"#tail": "\n          ", "#text": "."}}, "#text": "\n          ", "@id": "HE00E39337E58467A97F56617C4106DD8"}], "#text": "\n        ", "@id": "HEBD4A6E474E8460FB85F49F75C5E1E58"}], "#text": "\n      ", "@id": "H56A74351F92749F5B6C13719EAE830B0"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following new\n\t\t\t paragraph:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u20134(h) of the Social Security\n\t\t\t Act", "@value": "Social Security Act/s:1860D\u20134/ss:h"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 1305w\u2013104(h)", "@value": "usc/42/1305w\u2013104/h"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Improved appeals\n\t\t\t process under the Medicare operated prescription drug plan"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "paragraph": {"#tail": "\n        ", "subparagraph": [{"#tail": "\n          ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "an\n\t\t\t\tinitial review and determination made by the "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HA5A0BCBF8A8746BB89926B7C8DC52182", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "for appeals\n\t\t\t\tdenied during the initial review and determination, the option of an external\n\t\t\t\treview and determination by an independent entity selected by the\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H1A4482F7CA1A4FE99251C790BD1FE9DC", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\tdevelop a well-defined process for appeals for denials of benefits under this\n\t\t\t\tpart under the Medicare operated prescription drug plan. Such process shall be\n\t\t\t\tefficient, impose minimal administrative burdens, and ensure the timely\n\t\t\t\tprocurement of non-formulary drugs or exemption from formulary incentives when\n\t\t\t\tmedically necessary. Medical necessity shall be based on professional medical\n\t\t\t\tjudgment, the medical condition of the beneficiary, and other medical evidence.\n\t\t\t\tSuch appeals process shall include\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n            ", "@id": "H82BC9EBCFD9449AE9756F70C9F672DD9"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Social Security Act/s:1860D\u20134/ss:h/p:4/sp:A", "@proposed": "true"}, {"#tail": " shall consult with consumer and patient groups,\n\t\t\t\tas well as other key stakeholders to ensure the goals described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " are\n\t\t\t\tachieved.", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Social Security Act/s:1860D\u20134/ss:h/p:4/sp:A", "@proposed": "true"}], "#text": "In developing the appeals process under\n\t\t\t\t"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Consultation in\n\t\t\t\tdevelopment of process"}, "#text": "\n            ", "@id": "H22CF58D5CAAF486A8BA2AE8F81DC7C3E"}], "enum": {"#tail": "\n          ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Appeals process\n\t\t\t\tfor Medicare operated prescription drug plan"}, "#text": "\n          ", "@id": "HFA6E76987EE4464E8B9AE70C3B2A484A"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "H34A64632A019475EB09791411B1021DA"}, "#text": "\n      ", "@id": "HAE9B65482C234375865B37E3074DA8D2"}], "#text": "\n\t\t", "@id": "H4794E6AD368543F89F361210A17E5CF4"}}}